- Home
- EXPI vs ANIP Comparison
EXPI vs ANIP Comparison
Compare EXPI & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXPI
- ANIP
- Stock Information
- Founded
- EXPI 2008
- ANIP 2001
- Country
- EXPI United States
- ANIP United States
- Employees
- EXPI N/A
- ANIP N/A
- Industry
- EXPI Real Estate
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- EXPI Finance
- ANIP Health Care
- Exchange
- EXPI Nasdaq
- ANIP Nasdaq
- Market Cap
- EXPI 1.4B
- ANIP 1.2B
- IPO Year
- EXPI N/A
- ANIP N/A
- Fundamental
- Price
- EXPI $8.84
- ANIP $69.21
- Analyst Decision
- EXPI Hold
- ANIP Strong Buy
- Analyst Count
- EXPI 2
- ANIP 8
- Target Price
- EXPI $13.50
- ANIP $79.75
- AVG Volume (30 Days)
- EXPI 1.6M
- ANIP 423.7K
- Earning Date
- EXPI 05-06-2025
- ANIP 05-09-2025
- Dividend Yield
- EXPI 2.26%
- ANIP N/A
- EPS Growth
- EXPI N/A
- ANIP N/A
- EPS
- EXPI N/A
- ANIP N/A
- Revenue
- EXPI $4,567,672,000.00
- ANIP $614,376,000.00
- Revenue This Year
- EXPI $6.88
- ANIP $27.62
- Revenue Next Year
- EXPI $8.83
- ANIP $7.71
- P/E Ratio
- EXPI N/A
- ANIP N/A
- Revenue Growth
- EXPI 6.88
- ANIP 26.20
- 52 Week Low
- EXPI $8.64
- ANIP $52.50
- 52 Week High
- EXPI $15.39
- ANIP $70.18
- Technical
- Relative Strength Index (RSI)
- EXPI 37.79
- ANIP 60.35
- Support Level
- EXPI $8.87
- ANIP $61.43
- Resistance Level
- EXPI $9.61
- ANIP $68.82
- Average True Range (ATR)
- EXPI 0.55
- ANIP 3.38
- MACD
- EXPI -0.04
- ANIP -0.00
- Stochastic Oscillator
- EXPI 14.18
- ANIP 85.97
About EXPI eXp World Holdings Inc.
eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services. The company mainly operates in the United States and Canada, and it also has operations in the United Kingdom, Australia, South Africa, France, India, Portugal, and Mexico, among others.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.